Assessing Guardant Health: Insights From 7 Financial Analysts
Assessing Guardant Health: Insights From 7 Financial Analysts
评估Guardant Health：来自7位财务分析师的见解
In the latest quarter, 7 analysts provided ratings for Guardant Health (NASDAQ:GH), showcasing a mix of bullish and bearish perspectives.
在最新的季度中，7位分析师为Guardant Health（NASDAQ:GH）提供了评级，展示了看好和看淡的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $34.29, a high estimate of $44.00, and a low estimate of $28.00. This current average represents a 6.69% decrease from the previous average price target of $36.75.
分析师分析的12个月目标价提供了洞察力，平均目标为34.29美元，高估为44.00美元，低估为28.00美元。这个目前的平均值相比之前的平均目标价36.75美元下降了6.69%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
A clear picture of Guardant Health's perception among financial experts is painted with a thorough...
通过对近期分析师行动的彻底分析，...
登录免费看全文
登录/注册